Key result
Reynolds Risk Score improves CV risk discrimination and calibration over Framingham models in women.
Why the study?
Large differences in cardiovascular risk estimates exist between the Reynolds Risk Score and Framingham-based models, with clinical implications for statin therapy.
Does the Reynolds Risk Score improve global cardiovascular risk prediction compared to Framingham-based models in a multiethnic women's cohort?
Does the Reynolds Risk Score improve global cardiovascular risk prediction compared to Framingham-based models in a multiethnic women's cohort?
The Reynolds Risk Score provides better calibration and discrimination for cardiovascular risk prediction in women compared to Framingham models, which may impact statin therapy decisions.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in women but should not yet change practice; leaves open prospective validation and outcome impact.
The Reynolds Risk Score was better calibrated than the Framingham-based models in this large external validation cohort. The Reynolds score also showed improved discrimination overall and in black and white women. Large differences in risk estimates exist between models, with clinical implications for statin therapy.
No takes yet. Share an insight, caveat, or question.
Cook et al. (2012) studied this question. The Reynolds Risk Score demonstrated better calibration and improved discrimination compared to Framingham-based models for cardiovascular risk prediction in a multiethnic cohort of women.
Synapse has enriched 10 related papers. Consider them for comparative context: